Exchange Announcement • 16 Aug 2022 09:30
Exchange Announcement • 28 Jun 2022 15:52
Exchange Announcement • 15 Feb 2022 08:00
Exchange Announcement • 17 Aug 2021 08:00
Exchange Announcement • 16 Feb 2021 08:00
No more filings
ENTITY
Basilea Pharmaceutica Ag (BSLN SW)
Basilea Pharmaceutica Ag (BSLN SW)
56
Analysis
Health Care • Switzerland
Basilea Pharmaceutica AG operates as a biopharmaceutical company. The Company focuses on the research, development, and commercialization of products targeting the medical challenge of resistance and non-response to current treatment options for fungal infections, bacterial infections, and cancer.
more
x